These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20199896)

  • 1. Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs.
    Otsuji TG; Minami I; Kurose Y; Yamauchi K; Tada M; Nakatsuji N
    Stem Cell Res; 2010 May; 4(3):201-13. PubMed ID: 20199896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation.
    Kim C; Majdi M; Xia P; Wei KA; Talantova M; Spiering S; Nelson B; Mercola M; Chen HS
    Stem Cells Dev; 2010 Jun; 19(6):783-95. PubMed ID: 20001453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes.
    Otsuji TG; Kurose Y; Suemori H; Tada M; Nakatsuji N
    PLoS One; 2012; 7(9):e45010. PubMed ID: 22984602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes.
    Caspi O; Itzhaki I; Kehat I; Gepstein A; Arbel G; Huber I; Satin J; Gepstein L
    Stem Cells Dev; 2009; 18(1):161-72. PubMed ID: 18510453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype.
    Pekkanen-Mattila M; Chapman H; Kerkelä E; Suuronen R; Skottman H; Koivisto AP; Aalto-Setälä K
    Exp Biol Med (Maywood); 2010 Apr; 235(4):522-30. PubMed ID: 20407085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J; Kamalakar A; Yang X; Word B; Stockbridge N; Lyn-Cook B; Pang L
    Toxicol Sci; 2017 Mar; 156(1):25-38. PubMed ID: 28031415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The L-type Ca2+ channels blocker nifedipine represses mesodermal fate determination in murine embryonic stem cells.
    Nguemo F; Fleischmann BK; Gupta MK; Sarić T; Malan D; Liang H; Pfannkuche K; Bloch W; Schunkert H; Hescheler J; Reppel M
    PLoS One; 2013; 8(1):e53407. PubMed ID: 23320083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation.
    Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP
    Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes.
    Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS
    Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy.
    Pillekamp F; Haustein M; Khalil M; Emmelheinz M; Nazzal R; Adelmann R; Nguemo F; Rubenchyk O; Pfannkuche K; Matzkies M; Reppel M; Bloch W; Brockmeier K; Hescheler J
    Stem Cells Dev; 2012 Aug; 21(12):2111-21. PubMed ID: 22268955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.
    Sartiani L; Bettiol E; Stillitano F; Mugelli A; Cerbai E; Jaconi ME
    Stem Cells; 2007 May; 25(5):1136-44. PubMed ID: 17255522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.
    Lundy SD; Zhu WZ; Regnier M; Laflamme MA
    Stem Cells Dev; 2013 Jul; 22(14):1991-2002. PubMed ID: 23461462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth.
    Chow MZ; Geng L; Kong CW; Keung W; Fung JC; Boheler KR; Li RA
    Stem Cells Dev; 2013 Oct; 22(19):2678-90. PubMed ID: 23656529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
    Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes.
    Braam SR; Tertoolen L; van de Stolpe A; Meyer T; Passier R; Mummery CL
    Stem Cell Res; 2010 Mar; 4(2):107-16. PubMed ID: 20034863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes.
    Zhang D; Shadrin IY; Lam J; Xian HQ; Snodgrass HR; Bursac N
    Biomaterials; 2013 Jul; 34(23):5813-20. PubMed ID: 23642535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium handling in human embryonic stem cell-derived cardiomyocytes.
    Satin J; Itzhaki I; Rapoport S; Schroder EA; Izu L; Arbel G; Beyar R; Balke CW; Schiller J; Gepstein L
    Stem Cells; 2008 Aug; 26(8):1961-72. PubMed ID: 18483424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca²⁺ channel activators reveal differential L-type Ca²⁺ channel pharmacology between native and stem cell-derived cardiomyocytes.
    Kang J; Chen XL; Ji J; Lei Q; Rampe D
    J Pharmacol Exp Ther; 2012 May; 341(2):510-7. PubMed ID: 22353878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.
    Izumi-Nakaseko H; Hagiwara-Nagasawa M; Naito AT; Goto A; Chiba K; Sekino Y; Kanda Y; Sugiyama A
    J Pharmacol Sci; 2018 Aug; 137(4):372-378. PubMed ID: 30126708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.